Drug target · MTNR1A

MT1

Melatonin receptor 1A

1 compound in the CNS pipeline acts on MT1.

Compounds targeting MT1

CompoundActionAffinityLead programDeveloper
ALTO-300 (agomelatine)primarySmall moleculeAgonistKi 0.1 nMPhase 2Major depressive disorderAlto Neuroscience, Inc.